The Lyfebulb-Novo Nordisk Innovation Summit 2017 will recognize and empower international Patient Entrepreneurs with big ideas that disrupt the future of diabetes management
Pitch Competition: The pitch competition brings to the stage emerging Patient Entrepreneurs to pitch their invention or idea to Lyfebulb founders, Novo Nordisk R&D device leadership, researchers and engineers, and venture capitalists. Contestants will respond to a round of Q&A by the judging panel. The top three outstanding Patient Entrepreneurs will receive monetary awards to further develop their ideas:
- 1st Prize: 25,000USD
- 2nd Prize: 15,000USD
- 3rd Prize: 10,000USD
National and international recognition:
Visibility of the selected 10 finalists and the winner in particular.
Invitation to the Lyfebulb–Novo Nordisk Innovation Summit 2017 in Copenhagen as one of 10 Finalists.
- Travel to and from, and accommodation in Copenhagen, Denmark during the Summit.
- Opportunity to engage with Lyfebulb founders, Novo Nordisk device research leadership, researchers and engineers, and venture capitalists to interact and discuss how together we can disrupt the future of the management of diabetes.
International Judging Panel. The winner will be chosen by a judging panel made up of international representatives from the diabetes community.
Conditions to Apply
In order to apply for the Lyfebulb Innovation Award and the Innovation Summit, applicant must fulfil all the bellow conditions:
(a) The applicant must be working on innovative ideas and concepts for better management of diabetes using consumer or medical devices, or healthcare IT.
(b) The applicant is living with diabetes or has a close family member and/or loved one living with diabetes.
(c) The applicant must have established a registered company for developing and commercializing his or her idea, concept, product or service.
(d) The applicant’s idea, concept, product or service must be original and not include altered or copied products from third parties.
(e) The applicant’s idea, concept, product or services must, to the applicant’s knowledge, be free of third party rights, including intellectual property rights.
(f) Applicant must be 18 years of age or older.
(g) Participants will be required to sign an agreement with Novo Nordisk to ensure compliance with Novo Nordisk policies.
Patients participating in any U.S. government, state, or federally funded medical or prescription benefit programs, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, are not eligible to participate. This includes patients participating in a Managed Medicaid plan or who have Medicaid as secondary insurance.
No Referral or Product Use Requirement. Application imposes no referral or Novo Nordisk product or service use requirement.
Personal Data: By submitting an application for the Lyfebulb Innovation Award and the Innovation Summit, applicant expressly consents to: (i) the collection, use and retention by Lyfebulb and Novo Nordisk of the applicant’s personal and business information contained in the application for all purposes (including promotion and publicity) related to the Lyfebulb Innovation Award and the Innovation Summit; and (ii) the publication of the applicant’s name and entrepreneurial story on Lyfebulb’s and Novo Nordisk’s websites as well as on their social media channels (Facebook, Twitter, YouTube, Instagram, etc.). Any such information submitted will be transferred to servers located in the United States of America and treated under the laws of the United States of America.
Eligible Regions: Open for All.